A Systematic Review of the State of Economic Evaluation for Health Care in India (Q38602629)

4 September 2017

title

A Systematic Review of the State of Economic Evaluation for Health Care in India (English)

1 reference

4 September 2017

0 references

1 reference

Stephen Jan

5

0 references

Blake Angell

object named as

Blake Angell

series ordinal

3

1 reference

4 September 2017

Shankar Prinja

1

1 reference

4 September 2017

Akashdeep Singh Chauhan

series ordinal

2

1 reference

4 September 2017

Indrani Gupta

series ordinal

4

1 reference

4 September 2017

publication date

8 October 2015

1 reference

Applied Health Economics and Health Policy

4 September 2017

published in

1 reference

4 September 2017

volume

13

1 reference

4 September 2017

issue

6

1 reference

4 September 2017

page(s)

595-613

1 reference

Economic evaluation and decision making in the UK.

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Evidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Evidence-based decision on medical technologies in Asia Pacific: experiences from India, Malaysia, Philippines, and Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Assessing the quality of pharmacoeconomic studies in India: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Systematic literature review to evaluate and characterize the health economics and outcomes research studies in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-benefit analysis of installing dust control devices in the agate industry, Khambhat (Gujarat).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of malaria control interventions when malaria mortality is low: insecticide-treated nets versus in-house residual spraying in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The cost-effectiveness of a school-based smoking prevention program in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Economic evaluation of a task-shifting intervention for common mental disorders in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of "golden mustard" for treating vitamin A deficiency in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

A cost-effectiveness analysis of India's 2008 prohibition of smoking in public places in Gujarat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Screening for refractive error and fitting with spectacles in rural and urban India: cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Recurrent duodenal ulcer haemorrhage: a pharmacoeconomic comparison of various management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Alternative strategies to reduce maternal mortality in India: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of cervical-cancer screening in five developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The economic value of a visceral leishmaniasis vaccine in Bihar state, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of artesunate for the treatment of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Efficacy, safety and cost-effectiveness of insulin sensitizers as add-on therapy in metabolic syndrome in patients with secondary sulfonylurea failure: A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Economic evaluation of a surveillance program of hepatocellular carcinoma (HCC) in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost effectiveness of targeted HIV prevention interventions for female sex workers in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The cost-utility of telemedicine to screen for diabetic retinopathy in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Costs and health effects of screening and delivery of hearing aids in Tamil Nadu, India: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

A randomized controlled clinical trial to evaluate the efficacy, safety, cost-effectiveness and effect on PAI-1 levels of the three low-molecular-weight heparins--enoxaparin, nadroparin and dalteparin. The ESCAPe-END study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of public-funded options for cataract surgery in Mysore, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Antibiotic sensitivity pattern and cost-effectiveness analysis of antibiotic therapy in an Indian tertiary care teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost and effectiveness analysis of immunization service delivery support in Andhra Pradesh, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of misoprostol and prenatal iron supplementation as maternal mortality interventions in home births in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: cost-effectiveness, mortality, and morbidity reduction analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

A comparative study to evaluate efficacy, safety and cost-effectiveness between Whitfield's ointment + oral fluconazole versus topical 1% butenafine in tinea infections of skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness analysis of baclofen and chlordiazepoxide in uncomplicated alcohol-withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness of HIV treatment as prevention in serodiscordant couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Development and pilot testing of HIV screening program integration within public/primary health centers providing antenatal care services in Maharashtra, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The economics of screening infants at risk of hearing impairment: an international analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

A cost-effectiveness analysis of three different methods of psychiatric case finding in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The state of health economic research in South Africa: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

A systematic review of scope and quality of health economic evaluation studies in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

A systematic review of economic evaluations of health and health-related interventions in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Publication bias in clinical trials and economic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Bias in published cost effectiveness studies: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40258-015-0201-6

10.1007/S40258-015-0201-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1030336124

0 references

1 reference